| The Copenhagen Insulin and Metformin Therapy Trial (NCT00657943) | Steno Diabetes Center Copenhagen | 2008-04-01 |
| Low Glycemic Index Diet in Patients With Type 1 Diabetes (NCT01184703) | Steno Diabetes Center Copenhagen | 2007-06-01 |
| Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy (NCT00335413) | Steno Diabetes Center Copenhagen | 2006-06-01 |
| Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease (NCT00118976) | Steno Diabetes Center Copenhagen | 2005-03-01 |
| Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet (NCT00118937) | Steno Diabetes Center Copenhagen | 2003-12-01 |
| Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria (NCT00320879) | Steno Diabetes Center Copenhagen | 2003-09-01 |
| Spironolactone in Diabetic Nephropathy (NCT00317954) | Steno Diabetes Center Copenhagen | 2003-09-01 |
| Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes (NCT00118963) | Steno Diabetes Center Copenhagen | 2003-01-01 |
| Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet (NCT00118950) | Steno Diabetes Center Copenhagen | 2001-03-01 |
| Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy (NCT01521910) | Steno Diabetes Center Copenhagen | 1995-04-01 |
| Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy (NCT00311870) | Steno Diabetes Center Copenhagen | 1993-03-01 |
| Irbesartan in Type 2 Diabetes (NCT00317915) | Steno Diabetes Center Copenhagen | |